Knowledge hub

Blog

High-performance computing servers powering biomedical data pipelines and drug discovery.
Blog

Beyond the Petabytes: What It Really Takes to Power the Next Leap in Drug Discovery

Illustration of a human brain and neural connections symbolizing the synergy between human expertise and artificial intelligence in biotech.
Human-in-the-Loop: Achieving Impact with AI
Biomarker Identification & Validation with Multi-omics & AI
Discover the full potential of biomarkers identification and validation with multi-omics data and AI
Abstract data charts on screen representing biological data visualization techniques. integrated life science datasets
Choosing the right chart type for data visualization: A guide for biologists
Two scientists observing AI-driven cell analysis on a digital screen, representing decision-making in biotech innovation.
Build or Buy? Strategic Considerations for Biotech Companies Implementing AI Solutions
a detailed blog on AI in small-molecule drug discovery and how it impacts the drug discovery
AI in small-molecule drug discovery: A coming wave
biotech US market
AI in biotech: What the US market got right (and what it’s still learning)
an Majta presenting on AI and omics data in drug discovery at NextGen Omics Conference 2025.
From Data Chaos to Drug Discovery – Ardigen Talk at NextGen Omics Conference
Foundational Models for AI in Biology
Blog

Harnessing the potential of AI in drug discovery

BioIT 2025 insights
AI, Genomics and the Future of Medicine: Highlights from Bio-IT World Conference & Expo 2025
optimization strategies for scalable bioinformatics workflows.
The Scaling Paradox: Why Adding More Cloud Resources in Bioinformatics Doesn’t Always Solve the Problem
nextgen omics 2025
Insights from NextGen Omics 2025
The role of AI CROs in the next wave of biopharma transformation)
AI CROs and the Pharma Shift: The Next Wave of Drug Discovery Innovation
AI-driven target identification process in drug discovery.
What is target identification in drug discovery?
AI brain neurological diseases
Uncovering novel targets and approaches to treating neurological diseases
Latest progress and tools for de novo generation of peptides